Price
Target price
€15.70
€15.70
0.130%
0.02
0.130%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock CompuGroup Medical SE & Co. KGaA is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for CompuGroup
sharewise wants to provide you with the best news and tools for CompuGroup, so we directly link to the best financial data sources.
Financials
News
EQS-News: CompuGroup Medical appoints Prof. Dr. Daniel Gotthardt as new CEO
EQS-News: CompuGroup Medical appoints Prof. Dr. Daniel Gotthardt as new CEO
EQS-Adhoc: CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO
EQS-Adhoc: CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO
EQS-News: CompuGroup Medical wins digitization expert Ulf Hönick for the pharmacy business
EQS-News: CompuGroup Medical wins digitization expert Ulf Hönick for the pharmacy business
EQS-News: 100 million e-prescriptions issued in CGM's German practice software systems
EQS-News: 100 million e-prescriptions issued in CGM's German practice software systems
EQS-News: CompuGroup Medical SE & Co. KGaA publishes half-year figures for the financial year 2024
EQS-News: CompuGroup Medical SE & Co. KGaA publishes half-year figures for the financial year 2024
EQS-Adhoc: CompuGroup Medical SE & Co. KGaA expects lower revenues and therefore revises its financial year 2024 guidance
EQS-Adhoc: CompuGroup Medical SE & Co. KGaA expects lower revenues and therefore revises its financial year 2024 guidance
EQS-News: CGM receives C5 attestation according to BSI Criteria
EQS-News: CGM receives C5 attestation according to BSI Criteria
EQS-News: CompuGroup Medical strengthens market position in Northern Europe with the acquisition of Norwegian Pridok
EQS-News: CompuGroup Medical strengthens market position in Northern Europe with the acquisition of Norwegian Pridok
EQS-Adhoc: CompuGroup Medical SE & Co. KGaA: CompuGroup Medical acquires Pridok AS
EQS-Adhoc: CompuGroup Medical SE & Co. KGaA: CompuGroup Medical acquires Pridok AS
EQS-News: CompuGroup Medical Annual General Meeting: Shareholders approve dividend doubling to EUR 1.00
EQS-News: CompuGroup Medical Annual General Meeting: Shareholders approve dividend doubling to EUR 1.00
EQS-News: CompuGroup Medical with solid first quarter against strong prior year
EQS-News: CompuGroup Medical with solid first quarter against strong prior year
EQS-News: CompuGroup Medical successfully completes share buyback program
EQS-News: CompuGroup Medical successfully completes share buyback program
EQS-News: CGM proposes dividend of EUR 1.00 to be passed at virtual AGM in May
EQS-News: CGM proposes dividend of EUR 1.00 to be passed at virtual AGM in May
EQS-Adhoc: CompuGroup Medical SE & Co. KGaA adopts resolution on share buy-back program for up to 500,000 shares
EQS-Adhoc: CompuGroup Medical SE & Co. KGaA adopts resolution on share buy-back program for up to 500,000 shares
EQS-News: CompuGroup Medical US announces CEO transition
EQS-News: CompuGroup Medical US announces CEO transition